Inventor
SIIMAN OLAVI
US24 patents
⚠️ This page may combine multiple inventors who share the name “SIIMAN OLAVI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
COULTER CORP
14 patentsUS5248772ASep 28, 1993
Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
COULTER CORP117 citations98
US5776706AJul 7, 1998
Polymeric particles having a biodegradable gelatin or aminodextran coating and processes for making same
COULTER CORP91 citations96
US5707877AJan 13, 1998
Biodegradable gelatin-aminodextran particle coatings of and processes for making same
COULTER CORP74 citations96
US5639620AJun 17, 1997
Polymeric particles having a biodegradable gelatin or aminodextran coating and process for making same
COULTER CORP76 citations96
US5466609ANov 14, 1995
Biodegradable gelatin-aminodextran particle coatings of and processes for making same
COULTER CORP80 citations96
US5240640AAug 31, 1993
In situ use of gelatin or an aminodextran in the preparation of uniform ferrite particles
COULTER CORP72 citations96
US5169754ADec 8, 1992
Biodegradable particle coatings having a protein covalently immobilized by means of a crosslinking agent and processes for making same
COULTER CORP86 citations96
US5552086ASep 3, 1996
Immobilized metal colloids on dispersed polymer microspheres
COULTER CORP115 citations95
US5658741AAug 19, 1997
Anti-CD3 antibody-aminodextran conjugates for induction of T-cell activation and proliferation
COULTER CORP46 citations93
US5527713AJun 18, 1996
Anti-CD3 antibody-aminodextran conjugates for induction of T-cell activation and proliferation
COULTER CORP47 citations93
US5062991ANov 5, 1991
In situ use of gelatin in the preparation of uniform ferrite particles
COULTER CORP23 citations92
US5763204AJun 9, 1998
Preparation of preserved, non-infectious control cell for use in the identification of a disease through blood testing
COULTER CORP10 citations72
US5342754AAug 30, 1994
Preserved, non-infectious control cell for use in the identification of a disease through blood testing
COULTER CORP10 citations72
US5798217AAug 25, 1998
Method of analyzing tumor cell DNA content through tumor cell enrichment
COULTER CORP3 citations59
COULTER INT CORP
9 patentsUS6235540B1May 22, 2001
Semiconductor nanoparticles for analysis of blood cell populations and methods of making same
COULTER INT CORP86 citations95
US6074884AJun 13, 2000
Stable protein-nickel particles and methods of production and use thereof
COULTER INT CORP56 citations94
US5994089ANov 30, 1999
Simultaneous analyses of white blood cell subsets using multi-color, multi-intensity fluorescent markers in flow cytometry
COULTER INT CORP53 citations94
US5945293AAug 31, 1999
Protein-colloidal metal-aminodextran coated particle and methods of preparation and use
COULTER INT CORP76 citations93
US6514772B2Feb 4, 2003
Semiconductor nanoparticles for analysis of blood cell populations and methods of making same
COULTER INT CORP16 citations90
US6387622B1May 14, 2002
Ligand-aminodextran-marker conjugates and uses thereof
COULTER INT CORP37 citations89
US5891741AApr 6, 1999
Antibody-aminodextran-phycobiliprotein conjugates
COULTER INT CORP44 citations89
US5814468ASep 29, 1998
Methods of enumerating receptor molecules for specific binding partners on formed bodies and in solution
COULTER INT CORP40 citations87
US6696243B2Feb 24, 2004
Method for the analysis of soluble analytes
COULTER INT CORP5 citations63